BioSpace News Archive

Intuity Medical, Inc., a medical technology company with the mission of making life with diabetes easier, today announced the appointment of George Zamanakos as President and CEO.

ULTOMIRIS® (ravulizumab-cwvz) showed zero relapses in adults with neuromyelitis optica spectrum disorder (NMOSD) with median treatment duration of 73 weeks.

Vizgen today announced the availability of its MERSCOPE™ spatial genomics platform in Asia-Pacific (APAC), Europe, the Middle East and Africa (EMEA).

Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance.

2seventy bio, Inc. and JW Therapeutics today announced a strategic alliance to establish a translational and clinical cell therapy development platform designed to more rapidly explore T cell-based immunotherapy therapy products in the Chinese mainland, Hong Kong (China), and Macao (China).

Syantra, a precision healthcare company changing the way cancer is detected and treated, starting with Breast Cancer, appoints Dr. Massimo Cristofanilli , a world-renowned leader in the field of breast cancer, to its Scientific Advisory Board (SAB) effective Sept 1, 2022.

OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third quarter 2022 financial results after the close of the U.S. financial markets on Thursday, November 10, 2022.

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended September 30, 2022.

LEXEO Therapeutics (LEXEO), a clinical-stage biotech company advancing a pipeline of adeno-associated virus (AAV)-based gene therapy candidates for cardiovascular and central nervous system (CNS) diseases, today announced it will be presenting clinical and preclinical data at three upcoming scientific meetings.

Kura Oncology, Inc. today announced that it will report third quarter 2022 financial results before U.S. financial markets open on Thursday, November 3, 2022.